EPIC Program Annual Data Tables 2004-2005: Table VIII

Table VIII
Twenty Most Frequently Purchased Drugs^*

Rank by Number of Claims	Drug	Strength	Drug Type**	Number of Claims	EPIC Payments	Rank by Payment
Top 20 Totals				2,269,554	$168,508,867
Percent of Top 20 Drugs to Total Paid Claims				20.4%	22.5%
1	FUROSEMIDE	40MG	Gen	173,187	$744,896	174
2	LIPITOR	10MG	SS	170,901	$16,637,402	4
3	PLAVIX	75MG	SS	163,485	$28,794,696	1
4	FOSAMAX	70MG	SS	159,708	$15,459,348	7
5	NORVASC	5MG	SS	134,163	$8,030,765	12
6	HYDROCHLOROTHIAZIDE	25MG	Gen	129,366	$414,539	306
7	METOPROLOL TARTRATE	50MG	Gen	128,538	$565,455	232
8	PROTONIX	40MG	SS	112,131	$15,990,288	6
9	FUROSEMIDE	20MG	Gen	110,779	$423,137	293
10	LIPITOR	20MG	SS	110,462	$16,473,357	5
11	TOPROL XL	50MG	SS	101,719	$3,107,780	43
12	ATENOLOL	50MG	Gen	101,348	$561,563	234
13	NORVASC	10MG	SS	97,926	$7,846,014	14
14	PREVACID	30MG	SS	89,151	$17,574,094	3
15	METFORMIN HCL	500MG	Gen	85,304	$1,541,909	98
16	NEXIUM	40MG	SS	85,113	$17,767,780	2
17	AMBIEN	10MG	SS	81,874	$5,436,069	22
18	ACTONEL	35MG	SS	79,042	$7,029,027	16
19	ATENOLOL	25MG	Gen	78,495	$479,272	263
20	XALATAN	0.005%	SS	76,862	$3,631,476	35

^* Table VIII lists the top 20 drugs ranked by number of adjudicated claims for the program year (October 1, 2004-September 30, 2005) as well as the percentage of the totals they represent for the year.

^** Drug Type values are Gen='Generic' and SS='Sole Source'.